Dafna Yahav

11.0k total citations · 2 hit papers
207 papers, 5.5k citations indexed

About

Dafna Yahav is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Dafna Yahav has authored 207 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Epidemiology, 67 papers in Infectious Diseases and 32 papers in Clinical Biochemistry. Recurrent topics in Dafna Yahav's work include Antibiotic Resistance in Bacteria (32 papers), Bacterial Identification and Susceptibility Testing (32 papers) and Antibiotic Use and Resistance (29 papers). Dafna Yahav is often cited by papers focused on Antibiotic Resistance in Bacteria (32 papers), Bacterial Identification and Susceptibility Testing (32 papers) and Antibiotic Use and Resistance (29 papers). Dafna Yahav collaborates with scholars based in Israel, United States and Italy. Dafna Yahav's co-authors include Mical Paul, Leonard Leibovici, Jihad Bishara, Noa Eliakim‐Raz, Abigail Fraser, Adi Lador, Elad Goldberg, Benaya Rozen‐Zvi, Christian G. Giske and Vincent H. Tam and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dafna Yahav

188 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New β-Lactam–β-Lactamase Inhibitor Combinations

2020 362 citations Dafna Yahav, Christian G. Giske et al. Clinical Microbiology Reviews profile →
How do I manage nocardiosis?

2021 106 citations Ili Margalit, Elad Goldberg et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dafna Yahav Israel	41	1.8k	1.6k	1.3k	1.1k	645	207	5.5k
Francesco Giuseppe De Rosa Italy	36	2.0k 1.1×	1.7k 1.1×	1.6k 1.3×	1.2k 1.2×	808 1.3×	285	5.7k
Elda Righi Italy	38	1.7k 0.9×	1.7k 1.1×	1.5k 1.2×	878 0.8×	763 1.2×	141	5.8k
Anna S. Levin Brazil	43	2.0k 1.1×	1.5k 1.0×	2.2k 1.8×	1.2k 1.1×	865 1.3×	247	6.8k
Maddalena Giannella Italy	41	2.3k 1.3×	1.5k 0.9×	2.4k 1.9×	1.5k 1.4×	1.2k 1.8×	217	5.5k
Daniele Roberto Giacobbe Italy	38	1.9k 1.0×	1.8k 1.1×	2.2k 1.7×	1.4k 1.4×	1.1k 1.7×	201	5.2k
Wan Beom Park South Korea	44	2.1k 1.2×	3.2k 2.1×	1.2k 0.9×	673 0.6×	719 1.1×	259	6.5k
Konstantinos Z. Vardakas Greece	46	2.6k 1.5×	1.7k 1.1×	2.4k 1.9×	1.8k 1.7×	1.1k 1.7×	96	6.2k
Marc H. Scheetz United States	40	1.6k 0.9×	1.4k 0.9×	1.3k 1.0×	1.8k 1.7×	788 1.2×	199	4.4k
Michele Bartoletti Italy	35	1.5k 0.8×	902 0.6×	1.4k 1.1×	833 0.8×	754 1.2×	123	3.4k
Zeina A. Kanafani Lebanon	34	1.6k 0.9×	1.5k 1.0×	868 0.7×	526 0.5×	489 0.8×	120	4.4k

Countries citing papers authored by Dafna Yahav

Since Specialization

Citations

This map shows the geographic impact of Dafna Yahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafna Yahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafna Yahav more than expected).

Fields of papers citing papers by Dafna Yahav

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dafna Yahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafna Yahav. The network helps show where Dafna Yahav may publish in the future.

Co-authorship network of co-authors of Dafna Yahav

This figure shows the co-authorship network connecting the top 25 collaborators of Dafna Yahav. A scholar is included among the top collaborators of Dafna Yahav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dafna Yahav. Dafna Yahav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilboa, Mayan, Gili Regev‐Yochay, Eyal Meltzer, et al.. (2025). Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection. JAMA Network Open. 8(8). e2525252–e2525252.

Shepshelovich, Daniel, et al.. (2025). Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals. JAMA Internal Medicine. 185(4). 464–464. 1 indexed citations

Leibovitz, Eugene, Nathan Keller, Dafna Yahav, et al.. (2025). Clinical characteristics, outcomes, and subtype diversity in hospitalized human rhinovirus (HRV) patients. PLoS ONE. 20(11). e0335739–e0335739. 1 indexed citations

Ben‐Zvi, Haim, Ofir Wolach, Moshe Yeshurun, et al.. (2024). Utility of Echocardiogram in Neutropenic Patients with Gram-Positive Bacteremia: A Retrospective Study. Acta Haematologica. 147(6). 671–675.

Atamna, Alaa, et al.. (2024). Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials. Infection. 53(3). 1091–1099. 2 indexed citations

Margalit, Ili, et al.. (2024). Clinical impact of active screening cultures for carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis. American Journal of Infection Control. 52(12). 1351–1358. 2 indexed citations

Alves, Joana, et al.. (2024). Challenges of antimicrobial stewardship among older adults. European Journal of Internal Medicine. 124. 5–13. 5 indexed citations

Halpern, Naama, Ben Boursi, Einat Shacham‐Shmueli, et al.. (2023). Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer. Oncology and Therapy. 11(4). 513–519.

Tong, Steven Y. C., Dafna Yahav, & Nick Daneman. (2023). Which trial do we need? Highly bioavailable oral β-lactams versus quinolones or trimethoprim-sulfamethoxazole for gram-negative bacteraemia. Clinical Microbiology and Infection. 29(9). 1110–1113.

10.

Yelin, Dana, Ili Margalit, Mayssam Nehme, et al.. (2022). Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study. Journal of Clinical Medicine. 11(4). 898–898. 35 indexed citations

11.

Bitterman, Roni, Fidi Koppel, Cristina Mussini, et al.. (2021). Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen). BMJ Open. 11(2). e040210–e040210. 17 indexed citations

12.

Turjeman‬‏, ‪Adi, Vered Daitch, Noam Tau, et al.. (2021). Inadequate reporting of participants eligible for randomized controlled trials – A systematic review and meta-analysis. Journal of Clinical Epidemiology. 140. 125–134. 1 indexed citations

13.

Yahav, Dafna, et al.. (2020). New β-Lactam–β-Lactamase Inhibitor Combinations. Clinical Microbiology Reviews. 34(1). 362 indexed citations breakdown →

14.

Neuberger, Ami, et al.. (2020). Treatment of Bacteremia Caused by Enterobacter spp.: Should the Potential for AmpC Induction Dictate Therapy? A Retrospective Study. Microbial Drug Resistance. 27(3). 410–414. 8 indexed citations

15.

Shargian, Liat, Ofir Wolach, Uri Rozovski, et al.. (2020). Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia. Annals of Hematology. 99(12). 2939–2945. 1 indexed citations

16.

Shargian, Liat, Anat Gafter‐Gvili, Haim Ben‐Zvi, et al.. (2019). Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies – a retrospective study. Leukemia & lymphoma. 60(11). 2787–2792. 13 indexed citations

17.

Shargian, Liat, Ronit Gurion, Pia Raanani, Dafna Yahav, & Anat Gafter‐Gvili. (2018). Hypomethylating Agents-associated Infections—Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 18(9). 603–610.e1. 4 indexed citations

18.

Huttner, Angela, Anna Kowalczyk, ‪Adi Turjeman‬‏, et al.. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. Obstetrical & Gynecological Survey. 73(8). 456–457. 7 indexed citations

19.

Yahav, Dafna, et al.. (2015). Polymicrobial Q Fever and Enterococcal Aortic Prosthetic Valve Endocarditis with Aortic Root Abscess. Vector-Borne and Zoonotic Diseases. 15(5). 326–328. 8 indexed citations

20.

Ojukwu, Juliana U, Joseph Okebe, Dafna Yahav, & Mical Paul. (2009). Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database of Systematic Reviews. CD006589–CD006589. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact